Disclosed is a series of compounds acting as CDK4/6 inhibitors. Specifically disclosed are compounds as represented by formula (I), pharmaceutically acceptable salts or isomers thereof, pharmaceuticalcompositions containing same, and the use thereof in the preparation of drugs for treating cancers.